Source 1primary paper2025MED
Toolkit/contrast-enhanced ultrasound
contrast-enhanced ultrasound
Also known as: CEUS, contrast-enhanced ultrasound imaging
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Contrast-enhanced ultrasound (CEUS), utilizing microbubbles (MBs) and nanobubbles (NBs) to target vascular biomarkers, significantly enhances tumor visualization and demonstrates high sensitivity in molecular imaging.
Usefulness & Problems
Why this is useful
CEUS is presented as a real-time imaging approach for assessing placental and fetal perfusion in pregnancy. The review frames it as a functional bedside method for maternal imaging.; assessing placental perfusion in pregnancy; real-time bedside perfusion imaging in maternal-fetal medicine; CEUS uses microbubbles and nanobubbles to target vascular biomarkers and improve ultrasound-based tumor visualization. The abstract states that it shows high sensitivity in molecular imaging.; tumor visualization; molecular imaging; early tumor screening; staging; localization; Contrast-enhanced ultrasound is an imaging method that uses contrast agents to improve ultrasound readout. The review discusses both established microbubble-based use and emerging nanobubble-based extensions.; clinical imaging in cardiology; clinical imaging in radiology; echocardiography; emerging cancer diagnosis and therapy applications; nanobubble-based imaging studies
Source:
CEUS is presented as a real-time imaging approach for assessing placental and fetal perfusion in pregnancy. The review frames it as a functional bedside method for maternal imaging.
Source:
assessing placental perfusion in pregnancy
Source:
real-time bedside perfusion imaging in maternal-fetal medicine
Source:
CEUS uses microbubbles and nanobubbles to target vascular biomarkers and improve ultrasound-based tumor visualization. The abstract states that it shows high sensitivity in molecular imaging.
Source:
tumor visualization
Source:
molecular imaging
Source:
early tumor screening
Source:
staging
Source:
localization
Source:
Contrast-enhanced ultrasound is an imaging method that uses contrast agents to improve ultrasound readout. The review discusses both established microbubble-based use and emerging nanobubble-based extensions.
Source:
clinical imaging in cardiology
Source:
clinical imaging in radiology
Source:
echocardiography
Source:
emerging cancer diagnosis and therapy applications
Source:
nanobubble-based imaging studies
Problem solved
It addresses the limited functional perfusion information available from Doppler ultrasound and fetal MRI in placental disorders. The review positions it as a way to improve assessment of uteroplacental perfusion.; provides functional perfusion imaging where Doppler ultrasound and fetal MRI offer indirect or limited functional insight; It addresses limited tumor visualization by increasing contrast and sensitivity for molecular imaging in oncology.; enhances tumor visualization sensitivity in ultrasound imaging; It enables contrast-enhanced imaging in established clinical areas and emerging preclinical applications. In the review, it is the core modality through which nanobubble advantages are being explored.; provides ultrasound imaging contrast enhancement; supports imaging applications using microbubble and nanobubble agents
Source:
It addresses the limited functional perfusion information available from Doppler ultrasound and fetal MRI in placental disorders. The review positions it as a way to improve assessment of uteroplacental perfusion.
Source:
provides functional perfusion imaging where Doppler ultrasound and fetal MRI offer indirect or limited functional insight
Source:
It addresses limited tumor visualization by increasing contrast and sensitivity for molecular imaging in oncology.
Source:
enhances tumor visualization sensitivity in ultrasound imaging
Source:
It enables contrast-enhanced imaging in established clinical areas and emerging preclinical applications. In the review, it is the core modality through which nanobubble advantages are being explored.
Source:
provides ultrasound imaging contrast enhancement
Source:
supports imaging applications using microbubble and nanobubble agents
Problem links
enhances tumor visualization sensitivity in ultrasound imaging
LiteratureIt addresses limited tumor visualization by increasing contrast and sensitivity for molecular imaging in oncology.
Source:
It addresses limited tumor visualization by increasing contrast and sensitivity for molecular imaging in oncology.
provides functional perfusion imaging where Doppler ultrasound and fetal MRI offer indirect or limited functional insight
LiteratureIt addresses the limited functional perfusion information available from Doppler ultrasound and fetal MRI in placental disorders. The review positions it as a way to improve assessment of uteroplacental perfusion.
Source:
It addresses the limited functional perfusion information available from Doppler ultrasound and fetal MRI in placental disorders. The review positions it as a way to improve assessment of uteroplacental perfusion.
provides ultrasound imaging contrast enhancement
LiteratureIt enables contrast-enhanced imaging in established clinical areas and emerging preclinical applications. In the review, it is the core modality through which nanobubble advantages are being explored.
Source:
It enables contrast-enhanced imaging in established clinical areas and emerging preclinical applications. In the review, it is the core modality through which nanobubble advantages are being explored.
supports imaging applications using microbubble and nanobubble agents
LiteratureIt enables contrast-enhanced imaging in established clinical areas and emerging preclinical applications. In the review, it is the core modality through which nanobubble advantages are being explored.
Source:
It enables contrast-enhanced imaging in established clinical areas and emerging preclinical applications. In the review, it is the core modality through which nanobubble advantages are being explored.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
perfusion imagingultrasound contrast enhancement by intravascular microbubble agentsultrasound contrast enhancement by nanobubble agentsvascular biomarker targetingTechniques
Functional AssayTarget processes
No target processes tagged yet.
Input: Chemical
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The method uses intravascular microbubble contrast agents and ultrasound imaging protocols whose parameters vary across studies. Translation also requires safety monitoring and standardized acquisition settings.; requires intravascular microbubble contrast agents; clinical translation requires standardized protocols; clinical translation requires comprehensive safety monitoring and ethical oversight; The method requires ultrasound imaging together with microbubble or nanobubble contrast agents directed at vascular biomarkers.; requires microbubbles or nanobubbles targeting vascular biomarkers; It requires ultrasound instrumentation and a compatible contrast agent such as microbubbles or nanobubbles. For nanobubble applications, the abstract highlights the importance of formulations and acoustic characteristics.; requires compatible ultrasound contrast agents; nanobubble use involves nonlinear contrast imaging considerations and acoustic characteristics
The abstract does not establish long-term safety outcomes or standardized protocols. It also notes unresolved issues around sub-micron bubble populations and nanobubble distinctions.; protocol heterogeneity; absence of standardization; knowledge gaps regarding long-term outcomes; safety evidence lacks biomarker monitoring and long-term follow-up; The abstract does not claim that CEUS alone overcomes the extravascular limitations imposed by larger microbubble agents. That limitation is instead presented as a motivation for sub-micron nanobubbles.; application scope depends on the properties of the contrast agent used
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Observations
successHuman Clinicalmechanistic demo
Inferred from claim c2 during normalization. CEUS uses intravascular microbubble contrast agents that do not cross the placental barrier. Derived from claim c2. Quoted text: CEUS utilizes intravascular microbubble contrast agents (1-8 μm diameter) that do not cross the placental barrier, enabling safe maternal imaging.
Source:
microbubble diameter(1-8)
successHuman Clinicaltherapeutic use
Inferred from claim c3 during normalization. Human studies summarized in the paper reported zero clinically significant adverse events among 256 pregnant individuals undergoing CEUS-related evaluation. Derived from claim c3. Quoted text: Human studies demonstrate zero clinically significant adverse events among 256 cases, though critical gaps exist including absent biomarker monitoring and long-term follow-up.
Source:
clinically significant adverse events0human cases summarized256
Supporting Sources
Source 2primary paper2025MED
Source 3review2024MED
Ranked Claims
Contrast-enhanced ultrasound using microbubbles and nanobubbles enhances tumor visualization and shows high sensitivity in molecular imaging.
Contrast-enhanced ultrasound (CEUS), utilizing microbubbles (MBs) and nanobubbles (NBs) to target vascular biomarkers, significantly enhances tumor visualization and demonstrates high sensitivity in molecular imaging.
Current CEUS use in pregnancy is limited by protocol heterogeneity and lack of standardization.
Current limitations include significant protocol heterogeneity (MI 0.05-0.19, frequency 2-9 MHz) and absence of standardization.
frequency range 2-9 MHzmechanical index range 0.05-0.19
CEUS uses intravascular microbubble contrast agents that do not cross the placental barrier.
CEUS utilizes intravascular microbubble contrast agents (1-8 μm diameter) that do not cross the placental barrier, enabling safe maternal imaging.
microbubble diameter 1-8 μm
Multimodal ultrasound incorporating elastography and ABVS improves diagnostic accuracy when combined with MRI/CT.
Multimodal ultrasound (MU), incorporating techniques such as elastography and automated breast volume scanning (ABVS), achieves improved diagnostic accuracy when combined with MRI/CT.
Preclinical models showed that CEUS can detect placental perfusion changes, including a 54% reduction in perfusion index after uterine artery ligation.
Preclinical models confirm CEUS ability to detect placental perfusion Changes with 54% reduction in perfusion index following uterine artery ligation (p < 0.001).
p value 0.001reduction in perfusion index 54 %
Human studies summarized in the paper reported zero clinically significant adverse events among 256 pregnant individuals undergoing CEUS-related evaluation.
Human studies demonstrate zero clinically significant adverse events among 256 cases, though critical gaps exist including absent biomarker monitoring and long-term follow-up.
clinically significant adverse events 0human cases summarized 256
Contrast-enhanced ultrasound is presented as a promising, safe, real-time tool for assessing placental perfusion in maternal-fetal medicine.
To evaluate contrast-enhanced ultrasound (CEUS) as a promising, safe, and real-time tool for assessing placental perfusion and its potential application in maternal-fetal medicine.
The imaging potential of nanobubbles is linked in the review abstract to their high concentration and small size.
Nanobubble ultrasound imaging is still in its early stages but has shown strong potential in preclinical research and animal studies.
As technology advances, nanobubble contrast-enhanced ultrasound may find applications in cancer detection and treatment, cardiovascular imaging, and drug delivery.
Microbubbles are blood pool agents with diameters between 1 and 10 μm, which precludes their use in other extravascular applications.
Sub-micron nanobubbles have emerged to expand contrast-enhanced ultrasound beyond intravascular applications.
Clinically utilized ultrasound contrast agents are microbubbles composed of hydrophobic gas stabilized by a biocompatible shell.
Approval Evidence
3 sources10 linked approval claimsfirst-pass slug contrast-enhanced-ultrasound
Contrast-enhanced ultrasound (CEUS), utilizing microbubbles (MBs) and nanobubbles (NBs) to target vascular biomarkers, significantly enhances tumor visualization and demonstrates high sensitivity in molecular imaging.
Source:
To evaluate contrast-enhanced ultrasound (CEUS) as a promising, safe, and real-time tool for assessing placental perfusion and its potential application in maternal-fetal medicine.
Source:
Contrast-enhanced ultrasound is currently used worldwide with clinical indications in cardiology and radiology... Contrast-enhanced ultrasound imaging using these agents continues to gain traction, with new studies establishing novel imaging applications.
Source:
capabilitysupports
Contrast-enhanced ultrasound using microbubbles and nanobubbles enhances tumor visualization and shows high sensitivity in molecular imaging.
Contrast-enhanced ultrasound (CEUS), utilizing microbubbles (MBs) and nanobubbles (NBs) to target vascular biomarkers, significantly enhances tumor visualization and demonstrates high sensitivity in molecular imaging.
Source:
limitationsupports
Current CEUS use in pregnancy is limited by protocol heterogeneity and lack of standardization.
Current limitations include significant protocol heterogeneity (MI 0.05-0.19, frequency 2-9 MHz) and absence of standardization.
Source:
mechanism or safetysupports
CEUS uses intravascular microbubble contrast agents that do not cross the placental barrier.
CEUS utilizes intravascular microbubble contrast agents (1-8 μm diameter) that do not cross the placental barrier, enabling safe maternal imaging.
Source:
preclinical performancesupports
Preclinical models showed that CEUS can detect placental perfusion changes, including a 54% reduction in perfusion index after uterine artery ligation.
Preclinical models confirm CEUS ability to detect placental perfusion Changes with 54% reduction in perfusion index following uterine artery ligation (p < 0.001).
Source:
safety summarysupports
Human studies summarized in the paper reported zero clinically significant adverse events among 256 pregnant individuals undergoing CEUS-related evaluation.
Human studies demonstrate zero clinically significant adverse events among 256 cases, though critical gaps exist including absent biomarker monitoring and long-term follow-up.
Source:
tool capabilitysupports
Contrast-enhanced ultrasound is presented as a promising, safe, real-time tool for assessing placental perfusion in maternal-fetal medicine.
To evaluate contrast-enhanced ultrasound (CEUS) as a promising, safe, and real-time tool for assessing placental perfusion and its potential application in maternal-fetal medicine.
Source:
field maturitysupports
Nanobubble ultrasound imaging is still in its early stages but has shown strong potential in preclinical research and animal studies.
Source:
future applicationsupports
As technology advances, nanobubble contrast-enhanced ultrasound may find applications in cancer detection and treatment, cardiovascular imaging, and drug delivery.
Source:
rationalesupports
Sub-micron nanobubbles have emerged to expand contrast-enhanced ultrasound beyond intravascular applications.
Source:
scope summarysupports
Clinically utilized ultrasound contrast agents are microbubbles composed of hydrophobic gas stabilized by a biocompatible shell.
Source:
Comparisons
Source-stated alternatives
The abstract explicitly contrasts CEUS with Doppler ultrasound and fetal MRI as existing imaging modalities with indirect or limited functional insight.; The abstract contrasts CEUS with multimodal ultrasound approaches combined with MRI/CT.; The abstract contrasts different contrast-agent classes within CEUS rather than alternative imaging modalities. Microbubbles are the established agent class and nanobubbles are the emerging extension.
Source:
The abstract explicitly contrasts CEUS with Doppler ultrasound and fetal MRI as existing imaging modalities with indirect or limited functional insight.
Source:
The abstract contrasts CEUS with multimodal ultrasound approaches combined with MRI/CT.
Source:
The abstract contrasts different contrast-agent classes within CEUS rather than alternative imaging modalities. Microbubbles are the established agent class and nanobubbles are the emerging extension.
Source-backed strengths
real-time imaging; bedside use; no fetal exposure to contrast agents according to the review summary; high sensitivity in molecular imaging; uses targeted microbubbles and nanobubbles; already used worldwide clinically; continues to evolve through technological advancements; supports novel imaging applications
Source:
real-time imaging
Source:
bedside use
Source:
no fetal exposure to contrast agents according to the review summary
Source:
high sensitivity in molecular imaging
Source:
uses targeted microbubbles and nanobubbles
Source:
already used worldwide clinically
Source:
continues to evolve through technological advancements
Source:
supports novel imaging applications
Compared with imaging
The abstract explicitly contrasts CEUS with Doppler ultrasound and fetal MRI as existing imaging modalities with indirect or limited functional insight.; The abstract contrasts different contrast-agent classes within CEUS rather than alternative imaging modalities. Microbubbles are the established agent class and nanobubbles are the emerging extension.
Shared frame: source-stated alternative in extracted literature
Strengths here: real-time imaging; bedside use; no fetal exposure to contrast agents according to the review summary.
Relative tradeoffs: protocol heterogeneity; absence of standardization; knowledge gaps regarding long-term outcomes.
Source:
The abstract explicitly contrasts CEUS with Doppler ultrasound and fetal MRI as existing imaging modalities with indirect or limited functional insight.
Source:
The abstract contrasts different contrast-agent classes within CEUS rather than alternative imaging modalities. Microbubbles are the established agent class and nanobubbles are the emerging extension.
Compared with imaging surveillance
The abstract explicitly contrasts CEUS with Doppler ultrasound and fetal MRI as existing imaging modalities with indirect or limited functional insight.; The abstract contrasts different contrast-agent classes within CEUS rather than alternative imaging modalities. Microbubbles are the established agent class and nanobubbles are the emerging extension.
Shared frame: source-stated alternative in extracted literature
Strengths here: real-time imaging; bedside use; no fetal exposure to contrast agents according to the review summary.
Relative tradeoffs: protocol heterogeneity; absence of standardization; knowledge gaps regarding long-term outcomes.
Source:
The abstract explicitly contrasts CEUS with Doppler ultrasound and fetal MRI as existing imaging modalities with indirect or limited functional insight.
Source:
The abstract contrasts different contrast-agent classes within CEUS rather than alternative imaging modalities. Microbubbles are the established agent class and nanobubbles are the emerging extension.
Compared with multimodal ultrasound
The abstract contrasts CEUS with multimodal ultrasound approaches combined with MRI/CT.
Shared frame: source-stated alternative in extracted literature
Strengths here: real-time imaging; bedside use; no fetal exposure to contrast agents according to the review summary.
Relative tradeoffs: protocol heterogeneity; absence of standardization; knowledge gaps regarding long-term outcomes.
Source:
The abstract contrasts CEUS with multimodal ultrasound approaches combined with MRI/CT.
Compared with nanobubbles
The abstract contrasts different contrast-agent classes within CEUS rather than alternative imaging modalities. Microbubbles are the established agent class and nanobubbles are the emerging extension.
Shared frame: source-stated alternative in extracted literature
Strengths here: real-time imaging; bedside use; no fetal exposure to contrast agents according to the review summary.
Relative tradeoffs: protocol heterogeneity; absence of standardization; knowledge gaps regarding long-term outcomes.
Source:
The abstract contrasts different contrast-agent classes within CEUS rather than alternative imaging modalities. Microbubbles are the established agent class and nanobubbles are the emerging extension.
Compared with ultrasonography
The abstract explicitly contrasts CEUS with Doppler ultrasound and fetal MRI as existing imaging modalities with indirect or limited functional insight.; The abstract contrasts CEUS with multimodal ultrasound approaches combined with MRI/CT.
Shared frame: source-stated alternative in extracted literature
Strengths here: real-time imaging; bedside use; no fetal exposure to contrast agents according to the review summary.
Relative tradeoffs: protocol heterogeneity; absence of standardization; knowledge gaps regarding long-term outcomes.
Source:
The abstract explicitly contrasts CEUS with Doppler ultrasound and fetal MRI as existing imaging modalities with indirect or limited functional insight.
Source:
The abstract contrasts CEUS with multimodal ultrasound approaches combined with MRI/CT.
Ranked Citations
- 1.
- 2.
- 3.